Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 521

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 521
---
 contracts, equity swaps, collars and exchange funds, or other transactions that hedge or offset, or are designed to hedge or offset, any decrease in the market value of TuHURA’s equity securities.

#### Board Leadership Structure
TuHURA has structured its TuHURA Board of Directors in a way that TuHURA believes effectively serves its objectives of corporate governance and management oversight. TuHURA separates the roles of President and Chairman of the board of directors in recognition of the differences between the two roles. TuHURA believes that the President should be responsible for the day-to-day leadership and performance of TuHURA, while the Chairman of the board of directors should work with the President and the rest of the board of directors to set the strategic direction for TuHURA and provide guidance to, and oversight of the President. The Chairman also sets the agenda for meetings of the board of directors and presides over them.

Dr. Manuso, who is an independent director, was elected Chairman of the board of directors in 2024 in connection with the completion of the Kintara Merger. In this capacity, Dr. Manuso, among other things, calls and presides over board meetings, including meetings of the independent directors, and sets meeting agendas. In this role, Dr. Manuso can effectively coordinate between the TuHURA Board of Directors and management regarding risk management issues and the implementation of appropriate responses, and can help ensure the effective independent functioning of the TuHURA Board of Directors in its oversight responsibilities. Accordingly, the Chairman has substantial ability to shape the work of the TuHURA Board of Directors

<div align='center'>322</div>

**Role of the Board of Directors in Risk Oversight and Risk Management

One of key functions of TuHURA’s Board of Directors informed oversight of TuHURA’s risk management process. The TuHURA Board of Directors does not have a standing risk management committee, but rather administers this oversight function directly through the TuHURA Board of Directors as a whole, as well as through various standing committees of the TuHURA Board of Directors that address risks inherent in their respective areas of oversight.

Meetings of the Board, Board and Committee Member Attendance and Annual Meeting Attendance

Following the completion of the Kintara Merger that closed on October 18, 2024, the TuHURA Board of Directors met two times in 2024, the TuHURA audit committee met one time in 2024, the TuHURA compensation committee met one time in